A Non-interventional, Prospective, Observational Study of Treatment With APRemilast in Moderate psoriAsIS in Real Life clinicAL Practice (The 'APRAISAL' Study)

Trial Profile

A Non-interventional, Prospective, Observational Study of Treatment With APRemilast in Moderate psoriAsIS in Real Life clinicAL Practice (The 'APRAISAL' Study)

Active, no longer recruiting
Phase of Trial: Phase IV

Latest Information Update: 23 May 2018

At a glance

  • Drugs Apremilast (Primary)
  • Indications Plaque psoriasis
  • Focus Therapeutic Use
  • Acronyms APRAISAL
  • Sponsors Genesis Pharma
  • Most Recent Events

    • 11 May 2018 Planned End Date changed from 1 Apr 2019 to 10 Apr 2019.
    • 11 May 2018 Status changed from recruiting to active, no longer recruiting.
    • 07 Apr 2017 Planned End Date changed from 1 Mar 2019 to 1 Apr 2019.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top